SYNLOGIC, INC. Basic Shares Outstanding (Weighted Average)
SYNLOGIC, INC. (SYBX) reported Basic Shares Outstanding (Weighted Average) of 12.42 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 12.42M shares, a 0.81% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 12.39M shares, a 0.91% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 12.33M shares, a 0.83% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 12.32M shares, a 0.78% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 12.31M shares, a 0.95% increase from fiscal 2024.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 12.20M shares, a 87.57% increase from fiscal 2023.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 6.50M shares, a 35.98% increase from fiscal 2022.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 4.78M shares, a 91.36% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 12.42M shares 10-Q · filed 2026-08-11 | 12.41M shares 10-Q · filed 2026-08-11 | 12.38M shares derived: average of 3 quarters · filed 2026-08-11 | 12.36M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 12.39M shares 10-Q · filed 2026-05-14 | 12.36M shares derived: average of 2 quarters · filed 2026-05-14 | 12.35M shares derived: average of 3 quarters · filed 2026-05-14 | 12.34M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 12.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 12.32M shares derived: average of 2 quarters · filed 2026-03-12 | 12.32M shares derived: average of 3 quarters · filed 2026-08-11 | 12.31M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 12.32M shares 10-Q · filed 2025-11-13 | 12.32M shares derived: average of 2 quarters · filed 2026-08-11 | 12.31M shares 10-Q · filed 2025-11-13 | 12.29M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 12.32M shares 10-Q · filed 2026-08-11 | 12.30M shares 10-Q · filed 2026-08-11 | 12.28M shares derived: average of 3 quarters · filed 2026-08-11 | 12.26M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 12.28M shares 10-Q · filed 2026-05-14 | 12.25M shares derived: average of 2 quarters · filed 2026-05-14 | 12.24M shares derived: average of 3 quarters · filed 2026-05-14 | 12.23M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 12.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 12.22M shares derived: average of 2 quarters · filed 2026-03-12 | 12.22M shares derived: average of 3 quarters · filed 2026-03-12 | 12.20M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 12.22M shares 10-Q · filed 2025-11-13 | 12.21M shares derived: average of 2 quarters · filed 2025-11-13 | 12.19M shares 10-Q · filed 2025-11-13 | 12.15M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 12.20M shares 10-Q · filed 2025-08-07 | 12.17M shares 10-Q · filed 2025-08-07 | 12.12M shares derived: average of 3 quarters · filed 2025-08-07 | 10.26M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 12.13M shares 10-Q · filed 2025-05-08 | 12.08M shares derived: average of 2 quarters · filed 2025-05-08 | 9.62M shares derived: average of 3 quarters · filed 2025-05-08 | 8.38M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 12.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 8.36M shares derived: average of 2 quarters · filed 2025-03-06 | 7.13M shares derived: average of 3 quarters · filed 2025-03-06 | 6.50M shares 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | 4.70M shares 10-Q · filed 2024-11-12 | 4.69M shares derived: average of 2 quarters · filed 2024-11-12 | 4.66M shares 10-Q · filed 2024-11-12 | 4.68M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 4.68M shares 10-Q · filed 2024-08-08 | 70.22M shares 10-Q · filed 2023-08-10 | 4.64M shares 10-Q · filed 2024-08-08 | 69.65M shares 10-Q · filed 2023-08-10 | 4.67M shares derived: average of 3 quarters · filed 2024-08-08 | 4.70M shares derived: average of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | 4.60M shares 10-Q · filed 2024-05-14 | 69.07M shares 10-Q · filed 2023-05-11 | 4.66M shares derived: average of 2 quarters · filed 2024-05-14 | 4.71M shares derived: average of 3 quarters · filed 2024-05-14 | 21.56M shares derived: average of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | 4.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 4.76M shares derived: average of 2 quarters · filed 2024-03-19 | 27.21M shares derived: average of 3 quarters · filed 2024-03-19 | 4.78M shares 10-K · filed 2024-03-19 | 71.73M shares 10-K · filed 2023-03-29 | |||
| 2022-09-30 | 4.81M shares 10-Q · filed 2023-11-09 | 72.11M shares 10-Q · filed 2022-11-10 | 38.46M shares derived: average of 2 quarters · filed 2023-11-09 | 4.80M shares 10-Q · filed 2023-11-09 | 72.06M shares 10-Q · filed 2022-11-10 | 55.25M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 72.11M shares 10-Q · filed 2023-08-10 | 72.04M shares 10-Q · filed 2023-08-10 | 72.07M shares derived: average of 3 quarters · filed 2023-08-10 | 67.89M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 71.97M shares 10-Q · filed 2023-05-11 | 72.05M shares derived: average of 2 quarters · filed 2023-05-11 | 66.48M shares derived: average of 3 quarters · filed 2023-05-11 | 62.87M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 72.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 63.73M shares derived: average of 2 quarters · filed 2023-03-29 | 59.84M shares derived: average of 3 quarters · filed 2023-03-29 | 55.33M shares 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | 55.34M shares 10-Q · filed 2022-11-10 | 53.69M shares derived: average of 2 quarters · filed 2022-11-10 | 49.73M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 52.05M shares 10-Q · filed 2022-08-11 | 46.88M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |